37 CFR § 1.839 — Incorporation by (MPEP Coverage Index) – BlueIron IP
37 CFR § 1.839 Incorporation by
This page consolidates MPEP guidance interpreting 37 CFR § 1.839, including 16 rules from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Summary
This section details the sequence rules (37 CFR 1.831 – 37 CFR 1.839) that reissue applications must follow when disclosing nucleotide and amino acid sequences, ensuring proper processing and examination.
What this section covers
- Defines the content requirements for reissue applications involving nucleotide and amino acid sequences.
Key obligations
- Reissue applications must comply with the sequence rules (37 CFR 1.831 – 37 CFR 1.839) for nucleotide and amino acid sequences.
- Practitioners must ensure the sequence listing is properly incorporated by reference in the reissue application.
- Compliance with these rules ensures proper processing and examination of the reissue application.
Practice notes
- Review the specific sequence rules (37 CFR 1.831 – 37 CFR 1.839) for detailed guidance on formatting and submission of nucleotide and amino acid sequences.
- Ensure the sequence listing is properly incorporated by reference to avoid rejections or delays.
Official MPEP § 1.839 — Incorporation by
Source: USPTOLast Modified: 10/30/2024 08:50:22
1.839 Incorporation by reference.
- (a) Certain material is incorporated by reference into this subpart with the approval of the Director of the Federal Register under 5 U.S.C. 552(a) and 1 CFR part 51. All approved incorporation by reference (IBR) material is available for inspection at the USPTO and at the National Archives and Records Administration (NARA). Contact the USPTO’s Office of Patent Legal Administration at 571–272–7701. For information on the availability of this material at NARA, email fr.inspection@ nara.gov or go to www.archives.gov/ federal-register/cfr/ibr-locations.html . The material may be obtained from the source(s) in paragraph (b) of this section.
- (b) World Intellectual Property
Organization (WIPO), 34 chemin des Colombettes, 1211 Geneva 20
Switzerland,
www.wipo.int
.
- (1) WIPO Standard ST.26. WIPO Handbook on Intellectual Property Information and Documentation, Standard ST.26: Recommended Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language) including Annexes I–VII, version 1.6, approved November 25, 2022; IBR approved for §§ 1.831 through 1.834 .
- (2) [Reserved]
[Added 87 FR 30806, May, 20, 2022, effective July 1, 2022; para. (b)(1) revised, 88 FR 34089, May 26, 2023, effective July 1, 2023]
-
- Reissue
- Sequence Listing